Renapar

Manufacturer
Energique, Inc. | Apotheca Company
Effective date
2021-06-07
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 22:43:54

Label at a glance#

ProductRenapar
Active ingredientCHONDRODENDRON TOMENTOSUM ROOT, PETROSELINUM CRISPUM, SMILAX ORNATA ROOT, PORK KIDNEY, BRYONIA ALBA ROOT, MERCURIC CHLORIDE, RUBIA TINCTORUM ROOT, SOLIDAGO VIRGAUREA FLOWERING TOP, ELYMUS REPENS ROOT
Label structure9 sections

Dosage and administration

Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS:

OTC - ACTIVE INGREDIENT SECTION

(in each drop): 16.62% of Bryonia (Alba) 12X, Kidney (Suis) 6X, Mercurius Corrosivus 12X, Rubia Tinctorum 12X, Solidago Virgaurea 12X, Triticum Repens 12X; 0.10% of Pareira Brava 3X, Petroselinum Sativum 3X, Sarsaparilla (Smilax Regelii) 3X.

INDICATIONS:

OTC - PURPOSE SECTION

May temporarily relieve sudden desire to urinate, urination difficult and scanty, and frequent urging on urination.**

**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

WARNINGS:

WARNINGS SECTION

If pregnant or breastfeeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal is broken or missing.

Store in a cool, dry place.

KEEP OUT OF REACH OF CHILDREN:

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

INDICATIONS:

INDICATIONS & USAGE SECTION

May temporarily relieve sudden desire to urinate, urination difficult and scanty, and frequent urging on urination.**

**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

INACTIVE INGREDIENTS:

INACTIVE INGREDIENT SECTION

Demineralized water, 20% Ethanol.

QUESTIONS:

OTC - QUESTIONS SECTION

Dist. by Energique, Inc.

201 Apple Blvd

Woodbine, IA 51579   800.869.8078

PACKAGE LABEL DISPLAY:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ENERGIQUE

SINCE 1987

HOMEOPATHIC REMEDY

RENAPAR

1 fl. oz. (30 ml)

RenaparRenapar

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
44911-0280-12021-02-23C16284748780-1ba0f9c33-3a1a-a910-e053-dadaa90a0b85Drug Facts:
44911-0280-12021-01-29C16284748780-1ba0f9c33-3a1a-a910-e053-dadaa90a0b85Drug Facts:

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
44911-028044911-0280-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
b1e23b09-f362-494c-8bf4-700edfe80d43ca72ab79-cdcd-4bb6-a6dc-fae81fad499b2021-06-07WarningsExact identifier
spl id: b1e23b09-f362-494c-8bf4-700edfe80d43
spl set id: ca72ab79-cdcd-4bb6-a6dc-fae81fad499b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.